![Inside the GENOME artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/c8/a1/0e/c8a10ebf-7dab-7dcf-5168-f1009497da93/mza_6788305613998935850.jpg/100x100bb.jpg)
How COVID-19 Has Affected Academic Cancer Center Clinical Care and Research
Inside the GENOME
English - May 22, 2020 16:00 - 18 minutes - 12.5 MBMedicine Health & Fitness Science genetics oncology cancer hereditary testing genetic testing brca cancer genetics Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Telegenetics in Today's Climate
Next Episode: Navigating Patient Care via Telemedicine
In this episode, Dr. Slavin speaks with Dr. Tuya Pal about the opportunities and challenges she has seen from the COVID-19 pandemic surrounding clinical cancer care and research.
About Our Guest:
Dr. Tuya Pal, MD is Associate Director for Cancer Health Disparities and Ingram Associate Professor of Cancer Research at Vanderbilt-Ingram Cancer Center. She is a nationally recognized physician-scientist expert in hereditary cancer genetics. https://www.vicc.org/member/tuya-pal